SCLX: Scilex Holding Company Stock

by  •  • Comments Off on SCLX: Scilex Holding Company Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,121.46
Enterprise Value ($M) 1,160.71
Book Value ($M) -192.64
Book Value / Share -1.05
Price / Book -5.82
NCAV ($M) -244.05
NCAV / Share -1.33
Price / NCAV -4.60

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.80
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.15
Current Ratio 0.16

Balance Sheet (mrq) ($M)
Current Assets 41.55
Assets 92.95
Liabilities 285.59
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 56.59
Operating Income -92.79
Net Income -72.81

Cash Flow Statement (mra) ($M)
Cash From Operations 19.35
Cash from Investing -2.67
Cash from Financing -18.13

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-23 13D/A SCLX Stock Acquisition JV LLC 21.10
01-17 13G Oramed Pharmaceuticals Inc. 6.20

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 23,402 91,231 25.65
2025-04-16 119,179 334,135 35.67
2025-04-15 52,680 162,202 32.48
2025-04-14 742,391 1,787,491 41.53

(click for more detail)

Similar Companies
SABS – SAB Biotherapeutics, Inc. SAVA – Cassava Sciences, Inc.
SBFM – Sunshine Biopharma, Inc. SGMO – Sangamo Therapeutics, Inc.
SHPH – Shuttle Pharmaceuticals Holdings, Inc.


Financial data and stock pages provided by
Fintel.io